Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...

On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory ...

Jacob Sands, MD, discusses the data that support the FDA accelerated approval of Dato-DXd in EGFR-positive non–small cell ...

The analysis of FDA-approved next-in-class drugs also found that, among RCTs with head-to-head trials, fewer than 1 in 4 of ...

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

This will pave the way for accelerated infrastructure development and planned growth in nearby villages, officials said.

Avidity Biosciences (RNA) experienced a remarkable share price surge of ~900% from late 2023 to mid-2024. This is mainly due to the progress of three oligonucleotide candidates indicated for DMD ...

The annual rate of house price growth accelerated to 2.4% on average in July, Nationwide Building Society said.

The annual rate of house price growth accelerated to 2.4% on average in July, Nationwide Building Society said.

The CRL was given because the FDA did not consider the phase 1/2 IGNYTE trial to be an adequate and well-controlled clinical ...

The FDA recently unveiled a new national priority voucher program that would seek to trade faster drug approvals for lower ...